These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16670475)

  • 21. Pupil dilation using drops vs gel: a comparative study.
    Moisseiev E; Loberman D; Zunz E; Kesler A; Loewenstein A; Mandelblum J
    Eye (Lond); 2015 Jun; 29(6):815-9. PubMed ID: 25857606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ophthalmic Insert versus Eye Drops for Mydriasis in Neonates: A Randomized Clinical Trial.
    Bremond-Gignac D; Jacqz-Aigrain E; Abdoul H; Daruich A; Beresniak A; Baud O; Alberti C;
    Neonatology; 2019; 115(2):142-148. PubMed ID: 30481790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study.
    Bhurayanontachai P; Saengkaew S; Apiromruck P
    J Optom; 2017; 10(2):111-116. PubMed ID: 27321772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison study between pilocarpine and tropicamide drops on corneal topography and their effect on IL-6 and TNF-α levels in tear.
    Zhang Y; Zhao J
    Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):73-78. PubMed ID: 36227674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparison of mydriatic effect between two drugs of different mechanism.
    Park JH; Lee YC; Lee SY
    Korean J Ophthalmol; 2009 Mar; 23(1):40-2. PubMed ID: 19337478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Availability of TPD ophthalmic solution (mixture of Mydrin-P solution, Neosynesin Kowa solution, and Diclod solution) in regard to the corneal barrier function--clinical evaluation for vitrectomy in patients with diabetic retinopathy].
    Tokuda K; Hirowatari T; Kamei Y; Miyazaki Y; Matsubara M
    Nippon Ganka Gakkai Zasshi; 2002 Oct; 106(10):648-53. PubMed ID: 12420376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measurement of central corneal thickness in myopic eyes with ultrasound and Pentacam scheimpflug system].
    He YL; Li XX; Bao YZ; Liu GD; Hu YW
    Zhonghua Yan Ke Za Zhi; 2006 Nov; 42(11):985-8. PubMed ID: 17386135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of three madriatics on the human ocular aberrations].
    Yu J; Chen H; Hu JY; Xun PC
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):826-31. PubMed ID: 16191351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serious adverse side effects after pupillary dilation in preterm infants].
    Lux AL; Mouriaux F; Guillois B; Fedrizzi S; Peyro-Saint-Paul L; Denion E
    J Fr Ophtalmol; 2015 Mar; 38(3):193-8. PubMed ID: 25726252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tropicamide (1%): an effective cycloplegic agent for myopic children.
    Manny RE; Hussein M; Scheiman M; Kurtz D; Niemann K; Zinzer K;
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1728-35. PubMed ID: 11431435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pupil response to tropicamide following laser in situ keratomileusis.
    Chung HS; Feder RS
    J Cataract Refract Surg; 2005 Mar; 31(3):553-6. PubMed ID: 15811744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of commercial dilating agents on laser flare-cell measurements.
    Chin PK; Cuzzani OE; Gimbel HV; Sun R
    Can J Ophthalmol; 1996 Dec; 31(7):362-5. PubMed ID: 8971457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonic orbscans and tropicamide.
    Ortega-Usobiaga J; Damas-Mateache B; Martin-Reyes C; Llovet-Osuna F; Beltrán-Sanz J; Baviera-Sabater J
    J Refract Surg; 2011 May; 27(5):321. PubMed ID: 21553756
    [No Abstract]   [Full Text] [Related]  

  • 36. Contact dermatitis to both tropicamide and phenylephrine eye drops.
    Haroun-Díaz E; Ruíz-García M; De Luxán de la Lastra S; Pastor-Vargas C; De las Heras M; Sastre Domínguez J; Cuesta-Herranz J
    Dermatitis; 2014; 25(3):149-50. PubMed ID: 24819290
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
    Zeise MM; McDougall BW; Bartlett JD; Corliss D; Mitten L
    J Am Optom Assoc; 1996 Nov; 67(11):681-9. PubMed ID: 8979662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study of pupil dilation using the Mydriasert ophthalmic insert].
    Levet L; Touzeau O; Scheer S; Borderie V; Laroche L
    J Fr Ophtalmol; 2004 Dec; 27(10):1099-108. PubMed ID: 15687919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Orbscan II corneal topography in individuals with myopia.
    Wei RH; Lim L; Chan WK; Tan DT
    Ophthalmology; 2006 Feb; 113(2):177-83. PubMed ID: 16458090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical mydriatic and cycloplegic spray for Chinese children.
    Wong CY; Fan DS; Yu CB; Lam DS
    J Pediatr Ophthalmol Strabismus; 2003; 40(6):349-52. PubMed ID: 14655983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.